BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 23653446)

  • 1. Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.
    Sambandan D; Dao DN; Weinrick BC; Vilchèze C; Gurcha SS; Ojha A; Kremer L; Besra GS; Hatfull GF; Jacobs WR
    mBio; 2013 May; 4(3):e00222-13. PubMed ID: 23653446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria.
    Ojha AK; Baughn AD; Sambandan D; Hsu T; Trivelli X; Guerardel Y; Alahari A; Kremer L; Jacobs WR; Hatfull GF
    Mol Microbiol; 2008 Jul; 69(1):164-74. PubMed ID: 18466296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of Mycobacterium tuberculosis to Biofilm Growth Is Genetically Linked to Drug Tolerance.
    Richards JP; Cai W; Zill NA; Zhang W; Ojha AK
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501144
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterium Tuberculosis Biofilm - A new perspective.
    Nayak N
    Indian J Tuberc; 2015 Jan; 62(1):4-6. PubMed ID: 25857559
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.
    de Souza MV; Ferreira Mde L; Pinheiro AC; Saraiva MF; de Almeida MV; Valle MS
    ScientificWorldJournal; 2008 Jul; 8():720-51. PubMed ID: 18677428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis.
    Slama N; Jamet S; Frigui W; Pawlik A; Bottai D; Laval F; Constant P; Lemassu A; Cam K; Daffé M; Brosch R; Eynard N; Quémard A
    Mol Microbiol; 2016 Feb; 99(4):794-807. PubMed ID: 26538472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?
    Chakraborty P; Kumar A
    Microb Cell; 2019 Jan; 6(2):105-122. PubMed ID: 30740456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.
    Kerns PW; Ackhart DF; Basaraba RJ; Leid JG; Shirtliff ME
    Pathog Dis; 2014 Apr; 70(3):347-58. PubMed ID: 24453174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resuscitation-Promoting Factors Are Required for Mycobacterium smegmatis Biofilm Formation.
    Ealand C; Rimal B; Chang J; Mashigo L; Chengalroyen M; Mapela L; Beukes G; Machowski E; Kim SJ; Kana B
    Appl Environ Microbiol; 2018 Sep; 84(17):. PubMed ID: 29915116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidyl-prolyl isomerase-B is involved in
    Kumar A; Alam A; Grover S; Pandey S; Tripathi D; Kumari M; Rani M; Singh A; Akhter Y; Ehtesham NZ; Hasnain SE
    NPJ Biofilms Microbiomes; 2019; 5(1):3. PubMed ID: 30675370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PatA Regulates Isoniazid Resistance by Mediating Mycolic Acid Synthesis and Controls Biofilm Formation by Affecting Lipid Synthesis in Mycobacteria.
    Wang K; Deng Y; Cui X; Chen M; Ou Y; Li D; Guo M; Li W
    Microbiol Spectr; 2023 Jun; 11(3):e0092823. PubMed ID: 37212713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A piperidinol-containing molecule is active against
    Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
    J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
    Alahari A; Alibaud L; Trivelli X; Gupta R; Lamichhane G; Reynolds RC; Bishai WR; Guerardel Y; Kremer L
    Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay-guided isolation of a Mycobacterium tuberculosis bioflim inhibitor from Arisaema sinii Krause.
    Jiang CH; Gan ML; An TT; Yang ZC
    Microb Pathog; 2019 Jan; 126():351-356. PubMed ID: 30471433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Anti-Mycobacterial Biofilm Agents Based on the 2-Aminoimidazole Scaffold.
    Nguyen TV; Minrovic BM; Melander RJ; Melander C
    ChemMedChem; 2019 May; 14(9):927-937. PubMed ID: 30834698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of Mycobacterium tuberculosis biofilms.
    Kulka K; Hatfull G; Ojha AK
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms.
    Islam MS; Richards JP; Ojha AK
    Expert Rev Anti Infect Ther; 2012 Sep; 10(9):1055-66. PubMed ID: 23106280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial Biofilms: Revisiting Tuberculosis Bacilli in Extracellular Necrotizing Lesions.
    Basaraba RJ; Ojha AK
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28597824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.